Matt Shuham is a news writer for TPM. He was previously associate editor of The National Memo and managing editor of the Harvard Political Review. He is available by email at firstname.lastname@example.org and on Twitter @mattshuham.
As the COVID-19 pandemic overwhelms health care systems in New York and other hard-hit states around the country, some medical schools are offering a months-early graduation to students who can help to staff strained hospitals.
On Wednesday night, the organization that accredits MD programs in the United States published guiding principles for early graduations “in the context of the rapidly evolving COVID-19 pandemic.”
For weeks, as the novel coronavirus has spread across the globe and infected hundreds of thousands of people, there have been the skeptics — those who say “social distancing,” while proven to slow the spread of COVID-19 and save lives, isn’t worth the economic cost.
Comparing the threat of COVID-19 to automobile accidents, seasonal flu fatalities and suicides on Monday, President Donald Trump made his position on the novel coronavirus’ impact on the economy clear.
When Donald Trump boosted an old anti-malaria drug on Thursday as a potential therapy for COVID-19, falsely suggesting the FDA had approved it for use, he spurred a global rush for the drug that’s having serious knock-on effects.